Sabbà C, Buonamico P, Vendemiale G, Berardi E, Antonica G, Palmieri V, Merkel C, Palasciano G
Dipartimento Medicina Interna e Medicina Pubblica, Università di Bari, Italy.
Eur J Gastroenterol Hepatol. 2001 Feb;13(2):163-9. doi: 10.1097/00042737-200102000-00012.
BACKGROUND/AIMS: This double-blind study was designed to evaluate the haemodynamic effect of two drugs, propranolol and octreotide, and their combination in patients with cirrhosis.
Fifteen patients with cirrhosis were randomly assigned to two groups receiving either octreotide subcutaneously at 100 microg ('octreotide' group, n = 9) or propranolol orally at 40 mg followed by a subcutaneous dose of octreotide (100 microg) after 1 h ('propranolol + octreotide' group, n = 6); then, after 30 min, a standard meal was administered to both groups. The hepatic vein pressure gradient by hepatic vein catheterization, portal and superior mesenteric artery blood flow velocity, superior mesenteric artery pulsatility index by the echo-Doppler duplex system were recorded at baseline, 1 h after propranolol in the 'propranolol + octreotide' group, and in both groups 30 min after octreotide and 30 min after meal.
At fast, propranolol was more active in decreasing portal pressure (from 16 +/- 2.2 to 12.7 +/- 3.8 mmHg, -20%, P < 0.05) as compared to octreotide (from 18.6 +/- 4.8 to 16.6 +/- 4.3 mmHg, -11%, P < 0.05). Conversely, octreotide was more active on the mean blood flow velocity of superior mesenteric artery (from 22.8 +/- 5 to 19 +/- 4.5 cm/ s, -17%; P< 0.05). Octreotide administration in patients receiving beta-blockers showed, also, a trend to increase the mesenteric vascular resistances (pulsatility index from 3.14 +/- 0.69 to 3.68 +/- 1.29, +17%, not significant (NS)) which had not been affected by previous treatment with propranolol. After the meal, a reduction of the expected hyperaemic response occurred in both groups.
The combined acute haemodynamic effect of this association suggests the possible combination of these two drugs in critical situations, such as variceal bleeding in patients receiving beta-blockers. The simultaneous use of echo-Doppler and hepatic vein catheterization permitted us a more complete analysis of the acute haemodynamic events.
背景/目的:本双盲研究旨在评估普萘洛尔和奥曲肽两种药物及其联合应用对肝硬化患者的血流动力学影响。
15例肝硬化患者随机分为两组,一组皮下注射奥曲肽100μg(“奥曲肽”组,n = 9),另一组口服普萘洛尔40mg,1小时后皮下注射奥曲肽(100μg)(“普萘洛尔+奥曲肽”组,n = 6);然后,30分钟后,两组均给予标准餐。通过肝静脉插管测量肝静脉压力梯度,用超声多普勒双功系统记录门静脉和肠系膜上动脉血流速度、肠系膜上动脉搏动指数,记录基线、“普萘洛尔+奥曲肽”组普萘洛尔给药1小时后、两组奥曲肽给药30分钟后及餐后30分钟的数据。
快速给药时,与奥曲肽(从18.6±4.8降至16.6±4.3mmHg,-11%,P < 0.05)相比,普萘洛尔降低门静脉压力的作用更明显(从16±2.2降至12.7±3.8mmHg,-20%,P < 0.05)。相反,奥曲肽对肠系膜上动脉平均血流速度的作用更明显(从22.8±5降至19±4.5cm/s,-17%;P < 0.05)。在接受β受体阻滞剂治疗的患者中给予奥曲肽,肠系膜血管阻力也有增加趋势(搏动指数从3.14±0.69升至3.68±1.29,+17%,无显著性差异(NS)),而普萘洛尔先前治疗对此无影响。餐后,两组预期的充血反应均降低。
这种联合用药的急性血流动力学效应表明,在危急情况下,如接受β受体阻滞剂治疗的患者发生静脉曲张出血时,这两种药物可能联合使用。同时使用超声多普勒和肝静脉插管使我们能够更全面地分析急性血流动力学事件。